Specialization
Intensive Care Medicine
Focus of research
Complement activation in COVID-19
Amsterdam Neuroscience
-
Regional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients
Lim, E. H. T., van de Beek, D., de Bruin, S., Rückinger, S., Thielert, C. & PANAMO study group, 17 Apr 2025, In: BMJ Open Respiratory Research. 12, 1, e002206.Research output: Contribution to journal › Article* › Academic › peer-review
-
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome Medicine, (2023), 15, 1, (22), 10.1186/s13073-023-01173-8)
COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank & NIAID-USUHS COVID Study Group, Dec 2024, In: Genome medicine. 16, 1, p. 6 1 p., 6.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial
van Amstel, R. B. E., Slim, M. A., Lim, E. H. T., Rückinger, S., Seymour, C. W., Burnett, B. P., Bos, L. D. J., van Vught, L. A. & PANAMO study group, Dec 2024, In: Critical care (London, England). 28, 1, p. 210 1 p., 210.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications